Home/Pipeline/Stelara (Ustekinumab) Biosimilar

Stelara (Ustekinumab) Biosimilar

Psoriasis / Crohn's Disease

Phase 1Active

Key Facts

Indication
Psoriasis / Crohn's Disease
Phase
Phase 1
Status
Active
Company

About NeuClone

Australian biosimilar developer using a proprietary CHO platform to bring affordable biologics to market.

View full company profile